Looking for a new broker?
Evelo Biosciences, Inc. stock is up 0.3% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 December’s closed higher than November.
Evelo Biosciences, Inc. discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company also develops EDP1815, a whole-microbe candidate for the. treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19.
